Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 71

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 71
---
 interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our shares of common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for our shares of common stock. We face risks related to compliance with corporate governance laws and financial reporting standards. The Sarbanes-Oxley Act, as well as related new rules and regulations implemented by the SEC and the Public Company Accounting Oversight Board, require changes in the corporate governance practices and financial reporting standards for public companies. These laws, rules and regulations, including compliance with Section 404 of the Sarbanes-Oxley Act relating to internal control over financial reporting, referred to as Section 404, materially increased our legal and financial compliance costs and made some activities more time-consuming and more burdensome. Anti-takeover provisions contained in our Charter and bylaws, as well as provisions of Delaware law, could impair a takeover attempt. Our Charter contains provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. We are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together, these provisions may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities. These provisions will include:

| ● | no cumulative voting in the election of directors, which                  
 limits the ability of minority stockholders to elect director candidates; |

| ● | a classified board of directors with three-year staggered                                                 
 terms, which could delay the ability of stockholders to change the membership of a majority of the Board; |

| ● | the right of our Board to elect a director to fill a vacancy                                                                                   
 created by the expansion of our Board or the resignation, death or removal of a director in certain circumstances, which prevents stockholders 
 from being able to fill vacancies on our Board; and                                                                                            |

| ● | a prohibition on stockholder action by written consent, which                              
 forces stockholder action to be taken at an annual or special meeting of our stockholders. |

40 Our Charter provides that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to